453 Results

People

  1. Kelsen
    Kelsen
  2. Motzer
    Motzer
  3. Kris
    Kris
  4. Saltz
    Saltz
  5. Abrey
    Abrey
  6. O'Reilly
    O'Reilly
  7. Schwartz
    Schwartz
  8. Hudis
    Hudis
  9. Aghajanian
    Aghajanian
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)
  7. Center for Hematologic Malignancies (63)
  8. Epidemiology and Biostatistics (61)
  9. Biostatistics Service (60)
  10. Genitourinary Oncology Service (59)
  1. "leukopenia"
Formats
  1. Journal Article (435)
  2. Review (9)
  3. Conference Paper (4)
  4. Editorial (2)
  5. Research Letter (2)
  6. Miscellaneous (1)
Groups
  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)

More Groups

People
  1. David Kelsen (33)
  2. Robert Motzer (29)
  3. Mark Kris (25)
  4. Leonard Saltz (21)
  5. Eileen O'Reilly (18)
  6. Lauren Abrey (18)

More People

Years
  1. 2025 (10)
  2. 2024 (26)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Cancer (33)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (15)
  5. Gynecologic Oncology (14)
  6. Investigational New Drugs (14)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Springer (52)
  3. American Society of Clinical Oncology (43)
  4. Wiley Blackwell (39)
  5. American Association for Cancer Research (36)
  6. Oxford University Press (33)

More Publishers

Results (453)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
    Journal Article

    Topp, M. S.; Stelljes, M.; Zugmaier, G.; Barnette, P.; Heffner, L. T. Jr; Trippett, T.; Duell, J.; Bargou, R. C.; Holland, C.; Benjamin, J. E.; more...
    Leukemia (2018)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized BFORE trial
    Journal Article

    Cortes, J. E.; Gambacorti-Passerini, C.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Dyagil, I.; Glushko, N.; Milojkovic, D.; le Coutre, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
    Journal Article

    Smyth, L. M.; Monson, K. R.; Jhaveri, K.; Drilon, A.; Li, B. T.; Abida, W.; Iyer, G.; Gerecitano, J. F.; Gounder, M.; Harding, J. J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; Yu, K. H.; Kelsen, D. P.; Harding, J. J.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas
    Journal Article

    Reiss, S. N.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update
    Journal Article

    Hanna, N.; Johnson, D.; Temin, S.; Baker, S. Jr; Brahmer, J.; Ellis, P. M.; Giaccone, G.; Hesketh, P. J.; Jaiyesimi, I.; Leighl, N. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Is chemotherapy always required for cancer in pregnancy? An observational study
    Journal Article

    Walsh, E. M.; O’Kane, G. M.; Cadoo, K. A.; Graham, D. M.; Korpanty, G. J.; Power, D. G.; Carney, D. N.
    Irish Journal of Medical Science (2017)

    Fulltext@MSK | Save
  • Multicenter, phase 1, dose escalation study of hypofractionated stereotactic radiation therapy with bevacizumab for recurrent glioblastoma and anaplastic astrocytoma
    Journal Article

    Clarke, J.; Neil, E.; Terziev, R.; Gutin, P.; Barani, I.; Kaley, T.; Lassman, A. B.; Chan, T. A.; Yamada, J.; DeAngelis, L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma
    Journal Article

    Martin, T.; Baz, R.; Benson, D. M.; Lendvai, N.; Wolf, J.; Munster, P.; Lesokhin, A. M.; Wack, C.; Charpentier, E.; Campana, F.; more...
    Blood (2017)

    Fulltext@MSK | Save